Bowhead Specialty price target lowered to $40 from $43 at Citizens JMP

Citizens JMP lowered the firm’s price target on Bowhead Specialty (BOW) to $40 from $43 and keeps an Outperform rating on the shares. The firm expects Q3 results for the insurance sector to be highlighted by lighter-than-typical catastrophe losses, modest mark to market book value tailwinds, and potential for continued issues around casualty loss reserves, but thinks focus will be zeroed in on the pricing environment, the analyst tells investors in a research note.